The levels of a molecule named microRNA-31 may serve as indicators of disease severity and progression in adults and children with Crohn’s disease (CD). “For such a clinically heterogenous ... Read more
Switching Crohn’s disease patients from Remicade (infliximab) to its biosimilar Inflectra has no negative impact to treatment safety or effectiveness, a Phase 3 clinical trial shows. Pfizer and Celltrion Healthcare jointly presented ... Read more
Treatment with corticosteroids and high-dose Pulmicort (budesonide) are both effective induction therapies for patients with mild-to-moderate Crohn’s disease, though high-dose Asacol (mesalamine) also offers an effective alternative with fewer side ... Read more
Vitamin D levels may influence response to treatment with anti-TNFα medications in patients with inflammatory bowel disease (IBD), according to new research that also linked low vitamin D to ... Read more
RedHill Biopharma Ltd. An Israeli biopharmaceutical company announced that an independent Data and Safety Monitoring Board (DSMB) recommended their MAP US study to continue as planned without any modifications.
In an effort to raise support for families and patients suffering from inflammatory bowel diseases, the Crohn’s & Colitis Foundation of America (CCFA) recently announced three companies that are partnering with their Take Steps program to help ... Read more
According to a recent research project published in the November issue of the journal Clinical Gastroenterology and Hepatology, higher risks of ulcerative colitis may be associated with not sleeping the recommended ... Read more
A recent study published in Autoimmunity Reviews by Prof. Yehuda Shoenfeld highlights the major role that obesity plays, due to adipokines, in triggering and also prolonging autoimmune diseases. Autoimmune diseases such as Crohn’s disease and multiple sclerosis ... Read more